Editorial: COVID-19 and what it means for end-of-life care in ICU: Balancing the priorities

Bloomer, Melissa; Bouchoucha, Stéphane

doi:10.1016/j.colegn.2020.05.007

Cited by 9 publications

(8 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic has significantly affected endof-life care practices, which may have serious consequences for the experience of dying of patients and the experiences of their relatives. Health care providers were challenged in the provision of high-quality end-of-life care, by the rapid change of events, a shortage in personal protective equipment (PPE) and the largely increased number of dying patients [1,2]. The Dutch government implemented an 'intelligent lockdown', including rules about keeping distance and hygiene, the closing of cafes and restaurants and visitor restrictions for all health care institutions [3,4].…”

Section: Introductionmentioning

confidence: 99%

Dignity reflections based on experiences of end‐of‐life care during the first wave of the COVID‐19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO‐LIVE study)

Becqué

Geugten

Heide

et al. 2021

Scandinavian Caring Sciences

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Dignity reflections based on experiences of end‐of‐life care during the first wave of the COVID‐19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO‐LIVE study)

Becqué

Geugten

Heide

et al. 2021

Scandinavian Caring Sciences

View full text Add to dashboard Cite

show abstract

“…32 As expected, ICU admission had a statistically significant relationship with mortality which is due to the end-stage of the disease, so more subjects are going to die after ICU admission. 33 We found that values of primary CRP did not significantly differ between atorvastatin users and nonusers. Nonetheless, secondary CRP significantly decreased in the atorvastatin-taking group after taking medication at the hospital, so it seems CRP levels are not under the effects of COVID-19 medication or statin consumption easily.…”

Section: Discussionmentioning

confidence: 59%

The Association of Atorvastatin Therapy With COVID-19 Outcomes and Mortality

et al. 2022

View full text Add to dashboard Cite

Background: The world is still witnessing a largely ongoing spread of coronavirus disease 2019 (COVID-19); therefore, the scientific findings in this area need to be shared promptly. Objectives: This study aimed to assess the usefulness of Atorvastatin treatment in reducing COVID-19 mortality in patients with or without diabetes mellitus (DM) and to correlate them with C-reactive protein (CRP) levels. Methods: This study consecutively enrolled patients with pneumonia symptoms, positive lung CT scan, and confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on reverse transcription-polymerase chain reaction (RT-PCR). The outcome was defined as intensive care unit (ICU) admission and death. Clinical data and history of atorvastatin administration were evaluated. CRP levels were measured at baseline and repeated after one week in all patients. Results: A total of 200 patients were included. Their mean age was 60.5 (SD=16.5) years, 113 (56.5%) patients were male, 47 (23.5%) with pre-existing diabetes, and 64 (32%) patients were taking atorvastatin routinely. 68 (34%) required ICU admission of all the studied patients. No gender differences were found in ICU admission and death. The baseline CRP was not significantly different, but the secondary CRP was significantly different between DM and non-DM groups. Secondary CRP also showed a significant reduction in patients receiving atorvastatin (P=0.017). The mortality was the same in atorvastatin or non-atorvastatin groups (P=0.715). Conclusion: It seems that taking statin has only some beneficial effects on improving CRP levels in patients with COVID-19. To achieve a reliable result, clinical trials are recommended.

show abstract

“…Nurses are key to supporting family members, communicating with sensitivity (Bloomer et al, 2017; Brooks et al, 2019), providing practical support (Mossin & Landmark, 2011) and immediate bereavement care (Raymond et al, 2017). However, the COVID‐19 pandemic resulted in a multitude of changes to practice, and health service policymakers and clinicians have had to develop new ways to deliver high‐quality patient care, extending to family (Bloomer & Bouchoucha, 2020). Yet, in the context of the visitation restrictions associated with the COVID‐19 pandemic, nurses' and bereaved family members' experiences when a patient dies are not fully understood.…”

Section: Introductionmentioning

confidence: 99%

Perspectives of family‐centred care at the end of life during the COVID‐19 pandemic: A qualitative descriptive study

Bloomer

Yuen

Williams

et al. 2023

Journal of Clinical Nursing

Self Cite

View full text Add to dashboard Cite

Aim: To explore nurses' and family members' perspectives of family care at the end of life, during restricted visitation associated with the COVID-19 pandemic. Background: To minimise the transmission of COVID-19, stringent infection prevention and control measures resulted in restricted hospital access for non-essential workers and visitors, creating challenges for the provision of family-centred care at the end of life. Design: Qualitative descriptive approach based on naturalistic inquiry. Methods: At a large public hospital in Melbourne, Australia, individual semi-structured interviews were undertaken with 15 registered nurses who cared for patients who died during restricted visitation associated with the COVID-19 pandemic, and 21 bereaved family members. COREQ guidelines informed analysis and reporting.Results: Five themes developed from the data: (i) impact of visitor restrictions, which describes uncertain, ambiguous and arbitrary rules, onerous and inconsistent requirements; (ii) nurse-family communication; (iii) family-centred care and interrupted connections; (iv) well-being and negative emotions; and (v) suggestions for a better way, such as moving away from the black and whiteness of the rules, prioritising communication, compassion and advocacy. Conclusions:Negative consequences for communication and the patient-family connection at the end of life were felt deeply. The evolving COVID-19 rules that were frequently revised and applied at short notice, and the subsequent consequences for clinical practices and care were felt deeply.

show abstract

Editorial: COVID-19 and what it means for end-of-life care in ICU: Balancing the priorities

Cited by 9 publications

References 17 publications

Dignity reflections based on experiences of end‐of‐life care during the first wave of the COVID‐19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO‐LIVE study)

Dignity reflections based on experiences of end‐of‐life care during the first wave of the COVID‐19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO‐LIVE study)

The Association of Atorvastatin Therapy With COVID-19 Outcomes and Mortality

Perspectives of family‐centred care at the end of life during the COVID‐19 pandemic: A qualitative descriptive study

Contact Info

Product

Resources

About